Conversely, in pancreatic cancer, miR-30d suppresses the proliferation and invasiveness of the cancer by targeting the SOX4/PI3K-AKT axis, with its downregulation linked to poor patient prognosis [52]. This evidence concerns the gene SOX4 and pancreatic neoplasm.